» Articles » PMID: 28148575

Chronic Respiratory Disease - the Acceptable Epidemic?

Overview
Journal Clin Med (Lond)
Specialty General Medicine
Date 2017 Feb 3
PMID 28148575
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic obstructive pulmonary disease (COPD) is a major cause of disability and death in the UK but is an even greater problem in low income countries. It is assumed by many to be almost entirely attributed to smoking. However, smoking alone cannot account for the distribution of the disease in the world and there is accumulating evidence that the disease is overwhelmingly a disease of poverty. The size of the problem and the failure of current hypotheses to explain the distribution of chronic lung disease make the lack of funding in this area surprising. The failure of science funders to respond to the analysis of the Cooksey report, which pointed out the extreme discrepancy between the size of the problem and the paucity of research funding, represents a serious failure in science policy. The lack of urgency in the face of such a large burden of illness suggests a degree of complacency in the face of a disease that is overwhelmingly a disease of the poor.

Citing Articles

Impact of omitting annual reviews for COPD on patient reported care quality- outcomes from the Asthma+Lung COPD patient passport.

Williams P, Bachir L, Philip K, Cumella A, Polkey M, Laverty A BMJ Open. 2024; 14(4):e080282.

PMID: 38604645 PMC: 11015218. DOI: 10.1136/bmjopen-2023-080282.


Lung Disease and Social Justice: Chronic Obstructive Pulmonary Disease as a Manifestation of Structural Violence.

Williams P, Buttery S, Laverty A, Hopkinson N Am J Respir Crit Care Med. 2024; 209(8):938-946.

PMID: 38300144 PMC: 11531224. DOI: 10.1164/rccm.202309-1650CI.


Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases.

Chan Y, Singh S, Gulati M, Wadhwa S, Prasher P, Kumar D J Drug Deliv Sci Technol. 2022; 74:103541.

PMID: 35774068 PMC: 9221924. DOI: 10.1016/j.jddst.2022.103541.


Towards precision in defining COPD exacerbations.

Jenkins C Breathe (Sheff). 2022; 17(3):210081.

PMID: 35035551 PMC: 8753624. DOI: 10.1183/20734735.0081-2021.


The Impact of and Gene Polymorphisms in Pulmonary Diseases Including COVID-19.

Gintoni I, Adamopoulou M, Yapijakis C In Vivo. 2022; 36(1):13-29.

PMID: 34972696 PMC: 8765175. DOI: 10.21873/invivo.12672.


References
1.
Obeidat M, Wain L, Shrine N, Kalsheker N, Artigas M, Repapi E . A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLoS One. 2011; 6(5):e19382. PMC: 3098839. DOI: 10.1371/journal.pone.0019382. View

2.
Barker D . The intrauterine origins of cardiovascular and obstructive lung disease in adult life. The Marc Daniels Lecture 1990. J R Coll Physicians Lond. 1991; 25(2):129-33. PMC: 5377211. View

3.
Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

4.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

5.
Burney P, Hooper R . The use of ethnically specific norms for ventilatory function in African-American and white populations. Int J Epidemiol. 2012; 41(3):782-90. PMC: 3396311. DOI: 10.1093/ije/dys011. View